Haplo turns any lab's genetic test into instant, CPIC-based prescribing guidance — flagging the drugs that will harm your patient before the script is written. No genetics expert. No EHR project. Live in a day.
In ancient Greek, pharmakon meant both remedy and poison — the same substance, two opposite fates. Which one a drug becomes is written in the patient's genes. Haplo reads that line before you prescribe.
Poor metabolizer — minimal active drug formed. High stent-thrombosis risk. Switch to prasugrel or ticagrelor.
Poor SLCO1B1 function — sharply elevated myopathy risk. Use rosuvastatin or pravastatin instead.
Reduced clearance — start at 50% dose and titrate, or choose a non-CYP2C19 antidepressant.
Adverse drug reactions are among the leading causes of hospitalization, and a large share are predictable from a patient's genotype. The science is settled — CPIC publishes free guidelines for 160+ drugs. The gap is operational: results come back as dense PDFs, there's no genetics expert on staff, and Epic's genomics module is out of reach for the independent clinics and pharmacies where most prescribing happens.
are linked to adverse drug reactions — a large fraction genetically predictable and preventable.
have free, evidence-based CPIC prescribing guidelines — yet remain unused at the point of care.
outside academic centers, in the long tail of clinics and pharmacies with no decision-support tooling.
Upload results from any CLIA lab, a consumer raw file, or type star-alleles directly. Haplo is lab-agnostic — interpretation lives with us, not the panel.
Haplo maps each current or proposed medication to the genes that govern it and computes the patient's metabolizer phenotype in real time.
Color-coded flags, plain-English CPIC guidance, and specific alternative drugs — plus a branded report for the chart and the patient.
Interpretation is the moat, not the assay. Any panel, any lab, one consistent engine — so clinics aren't locked to a single test vendor.
Web-based and standalone on day one. Optional FHIR / EHR write-back when you're ready — but never a prerequisite to value.
Every recommendation cites its CPIC or DPWG source. Defensible for clinicians, auditable for compliance, credible for payers.
Reports structured to support billable PGx-guided care, turning a safety tool into a revenue line for the practice.
A single genetically-predictable drug reaction — a clopidogrel non-responder's stent thrombosis, a DPYD toxicity admission — costs a health system tens of thousands of dollars. Haplo is priced far below a single avoided event, per clinic.
Simple, predictable seats — no per-test toll, no lock-in to a lab. Annual plans below.
See Haplo run on your own panels. Fifteen minutes, and you'll flag risks you're missing today.